Martingale Asset Management’s Medifast MED Stock Holding History

Martingale Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,501	Closed	-$438K	–	1037
2018 Q4	$438K	Sell	3,501 -1,600	-31%	-$274K	0.01%	877
2018 Q3	$1.13M	Sell	5,101 -4,400	-46%	-$892K	0.01%	700
2018 Q2	$1.52M	Sell	9,501 -33,704	-78%	-$4.31M	0.02%	633
2018 Q1	$4.04M	Sell	43,205 -7,501	-15%	-$560K	0.05%	348
2017 Q4	$3.54M	Sell	50,706 -9,600	-16%	-$637K	0.05%	382
2017 Q3	$3.58M	Sell	60,306 -200	-0.3%	-$9.95K	0.05%	409
2017 Q2	$2.51M	Hold	60,506	–	–	0.04%	488
2017 Q1	$2.69M	Buy	60,506 +2,992	+5%	+$129K	0.04%	464
2016 Q4	$2.4M	Buy	57,514 +8	+0%	+$322	0.03%	492
2016 Q3	$2.17M	Buy	57,506 +43,900	+323%	+$1.57M	0.03%	491
2016 Q2	$453K	Buy	+13,606	New	+$439K	0.01%	685

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

HCM

Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Martingale Asset Management's MED Position: Q1 2019 in Review

Martingale Asset Management sold out of Medifast (MED) in Q1 2019, closing a stake of 3,501 shares — an estimated $438K sold.

Martingale Asset Management first reported a position in MED in Q2 2016 and held it in 11 quarters. The position peaked at $4.04M in Q1 2018. 246 funds tracked by Wall St. Rank hold MED as of Q1 2019.

Martingale Asset Management reported no remaining Medifast position as of Q1 2019 after selling out during the quarter.
Martingale Asset Management sold 3,501 Medifast shares in Q1 2019, an estimated $438K.
Martingale Asset Management first reported a position in Medifast in Q2 2016 and held it in 11 quarters.
Martingale Asset Management's Medifast position peaked at $4.04M in Q1 2018.
246 funds tracked by Wall St. Rank held Medifast as of Q1 2019.

Based on Martingale Asset Management's 13F filing for Q1 2019, filed 8 May 2019.